Hannigan
Andy Hannigan, Thatcham GB
Patent application number | Description | Published |
---|---|---|
20160111778 | Multiple-Input Multiple-Output Antenna System and Apparatus - A multiple-input multiple-output (MIMO) antenna system includes a first elongated antenna connected to a first feed point, comprising a radiator configured to resonate in at least one frequency band; a second elongated antenna connected to a second feed point, comprising a radiator configured to resonate in at least one frequency band; a support element, whereto the first and the second elongated antenna being attached parallel with a first distance. The antenna system further includes an elongated conductive element connected to a ground and attached to the support element, the elongated conductive element configured to reduce coupling between the first and the second radiator. | 04-21-2016 |
Gregory Hannigan, Tornoto CA
Patent application number | Description | Published |
---|---|---|
20110059479 | MODULATION OF THE INTEGRIN LINKED KINASE SIGNALING PATHWAY TO PROMOTE CARDIAC CELL PROLIFERATION AND SELF-RENEWAL - The invention relates to a process for identification, amplification and differentiation of cardiac stem cells by utilizing an ILK based protocol. The invention further relates to a process for post myocardial infarction (IVII) remodeling by way of the integrin linked kinase (ILK) signaling pathway. Still further, the invention relates to a process for affecting an ability to control and/or manipulate stem cell frequency, cellular fate, self-renewal, multilineage differentiation, and potential for oncogenesis in cardiac tissue derived from embryonic stem cells, fetal tissue or adult tissue comprising modulation of ILK signaling amplification whereby stem cell renewal and expansion results. | 03-10-2011 |
20120177627 | UPREGULATION OF INTEGRIN LINKED KINASE (ILK) TO PROVIDE CARDIOPROTECTIVE EFFECTS - Modulation of the integrin-linked kinase (ILK) signaling pathway is used to enhance the remodeling process relevant to a wide range of cardiac diseases. More specifically, a process to instigate beneficial human cardiac hypertrophy or for post myocardial infraction (MI) remodeling comprising illiciting an overexpression of ILK, is described. The ILK signaling pathway is also used as a means for cardiac stem cell proliferation and self-renewal. | 07-12-2012 |
Gregory Hannigan, Toronto CA
Patent application number | Description | Published |
---|---|---|
20080274491 | Modulation of the Integrin Linked Kinase Signaling Pathway to Promote Cardiac Cell Proliferation and Self-Renewal - Modulation of the integrin-linked kinase (ILK) signaling pathway is used to enhance the remodeling process relevant to a wide range of cardiac diseases. More specifically, a process to instigate beneficial human cardiac hypertrophy or for post myocardial infarction (MI) remodeling comprising illiciting an overexpression of ILK, is described. The ILK signaling pathway is also used as a means for cardiac stem cell proliferation and self-renewal | 11-06-2008 |
20090203769 | Modulation of the integrin-linked kinase signaling pathway provides beneficial human cardiac hypertrophy and post myocardial infarction remodeling - Modulation of the integrin-linked kinase (ILK) signaling pathway is used to enhance the remodeling process relevant to a wide range of cardiac diseases. More specifically, a process for mediating a broadly adaptive form of human cardiac hypertrophy and a protective process for post myocardial infarction (MI), both comprising illiciting an overexpression of ILK, are described. Upregulation of ILK is also used in a process for affecting ILK mediated reduction of infarct size and beneficial increase in the left ventricular mass post MI. | 08-13-2009 |